While over-the-counter drug distribution varies in each of Europe's 15major markets, some common themes are emerging, says a new study from James Dudley Management.
The report says the nonprescription-bound drugs market has grown 33% since 1990 in the 15 countries, to a value of $15.6 billion at manufacturers' prices in 1996. Almost 90% of health care distribution flows through Europe's 220,000 pharmacies, compared with 45% in the USA. Retail pharmacies are the heart of the distribution system and, except for the Netherlands, are the primary source of purchase for OTCs. Common trends include:
- moves to abolish resale price maintenance on OTCs are underway in Germany, the Netherlands and the UK;
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze